OUR PRODUCTS

MOBILE APPS

GENERAL INFO

SCYX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

SCYNEXIS (SCYX) Earnings Date & Reports

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

SCYX is expected to report earnings to rise 7.14% to -15 cents per share on November 05

Q3'25

Est.

$-0.15

Q2'25

Beat

by $0.06

Q1'25

Beat

by $0.10

Q4'24

Beat

by $0.06

Q3'24

Beat

by $0.08

The last earnings report on August 13 showed earnings per share of -14 cents, beating the estimate of -20 cents. With 106.24K shares outstanding, the current market capitalization sits at 32.77M.

View a ticker or compare two or three

Compare

SCYX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For SCYX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SCYX showed earnings on August 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a company which engages in discovery, development and commercialization of novel anti infectives

Industry PharmaceuticalsGeneric

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

1 Evertrust Plaza

Phone

+1 201 884-5485

Employees

Web

https://www.scynexis.com